Related Experiment Videos
Preimplantation embryo chromosome analysis by primed in situ labeling method
F Pellestor1, A Girardet, B Andréo
1Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Fertility and Sterility
|November 1, 1996
Summary
Primed in situ labeling (PRINS) is a reliable method for preimplantation genetic diagnosis. This technique efficiently detects aneuploidy and determines gender in embryos, improving IVF outcomes.
Area of Science:
- Genetics
- Embryology
- Reproductive Medicine
Background:
- Preimplantation genetic diagnosis (PGD) is crucial for identifying chromosomal abnormalities in embryos.
- Traditional methods can be time-consuming and complex.
- A need exists for efficient and reliable PGD techniques.
Purpose of the Study:
- To evaluate the efficacy of the primed in situ labeling (PRINS) method for preimplantation genetic diagnosis.
- To assess PRINS for detecting numerical chromosomal abnormalities and determining gender in human embryos.
Main Methods:
- PRINS was performed on 10 morphologically abnormal preimplantation embryos from IVF patients.
- Specific primers for chromosomes 9, 13, 16, 18, 21, X, and Y were used.
- Interphase nuclei from poor-quality embryos were analyzed for numerical abnormalities.
Main Results:
- The PRINS labeling reaction for three chromosomes was completed within 2.30 hours.
- Only 3 out of 10 analyzed embryos were chromosomally normal.
- Mosaicism, aneuploidy, and haploidy were detected in the remaining 7 embryos.
Conclusions:
- PRINS is a simple and reliable screening tool for gender determination and aneuploidy detection.
- This technique can significantly enhance preimplantation genetic diagnosis procedures.
- PRINS offers a promising approach for improving IVF success rates.